This is actually becoming somewhat commonplace. For example, in many cutting-edge cancer therapies, blood is drawn from the patient, processed in tissue-culture suites on site to extract the patient’s immune cells and sensitize them to some marker expressed by their specific cancer cells, and then the modified immune cells are returned to the patient room and transfused back into their bodies. It’s not cheap per se but it’s something that most top-tier cancer centers can do, and to do the similar process of extracting stem cells, inducing them to transform into pancreatic islet cells, and transplanting those into the patient’s pancreas isn’t that big of a jump – and it’d be cheaper than a lifetime of insulin in any case. It also points the way towards treating other kinds of organ failure without the risk of rejection, too.
This is actually becoming somewhat commonplace. For example, in many cutting-edge cancer therapies, blood is drawn from the patient, processed in tissue-culture suites on site to extract the patient’s immune cells and sensitize them to some marker expressed by their specific cancer cells, and then the modified immune cells are returned to the patient room and transfused back into their bodies. It’s not cheap per se but it’s something that most top-tier cancer centers can do, and to do the similar process of extracting stem cells, inducing them to transform into pancreatic islet cells, and transplanting those into the patient’s pancreas isn’t that big of a jump – and it’d be cheaper than a lifetime of insulin in any case. It also points the way towards treating other kinds of organ failure without the risk of rejection, too.